Orthofix International (OFIX) Tops Q2 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Orthofix Reports Second Quarter 2021 Results
August 6, 2021 7:00 AM EDTNet sales of $121 million, up 66% compared to prior year and 5% compared to the second quarter of 2019 U.S. Spinal Implants net sales grew 56% compared to prior year and 37% over the second quarter of 2019 Strong performance from our U.S. M6-C artificial cervical disc and FITBONE® limb lengthening system with approximately $9 million in combined sales Company raises full year 2021 revenue and adjusted EBITDA guidance
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported its financial... More
